Literature DB >> 11060592

The role of nitric oxide in nociception.

Z D Luo1, D Cizkova.   

Abstract

Pharmacologic, electrophysiologic, and immunohistochemical studies have suggested a role of nitric oxide (NO) in nociception processing. Recent studies have indicated that NO may modulate spinal and sensory neuron excitability through multiple mechanisms that may underlie its distinctive roles in different pain states. Differential regulation of a family of NO-producing enzymes, NO synthases, contributes mainly to the complexity underlying the role of NO in nociception. This review summarizes the latest advances in our understanding of the contribution of NO to pain transduction. Possible cellular mechanisms regarding the connection between NO production and the abnormal sensation derived from different stimuli and pathologic conditions are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060592     DOI: 10.1007/s11916-000-0070-y

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  49 in total

1.  Antinociceptive properties and nitric oxide synthase inhibitory action of new ruthenium complexes.

Authors:  A Beirith; T B Creczynski-Pasa; V R Bonetti; M Konzen; I Seifriz; M S Paula; C V Franco; J B Calixto
Journal:  Eur J Pharmacol       Date:  1999-03-26       Impact factor: 4.432

2.  Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine.

Authors:  Tomosada Sugimoto; Gary J Bennett; Keith C Kajander
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

3.  Gamma subunit dependent modulation by nitric oxide (NO) in recombinant GABAA receptor.

Authors:  S Fukami; I Uchida; T Mashimo; M Takenoshita; I Yoshiya
Journal:  Neuroreport       Date:  1998-04-20       Impact factor: 1.837

4.  NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat.

Authors:  X Chen; J D Levine
Journal:  J Neurophysiol       Date:  1999-03       Impact factor: 2.714

5.  Intrathecal oxotremorine affects formalin-induced behavior and spinal nitric oxide synthase immunoreactivity in rats.

Authors:  B Przewlocka; J Mika; F Capone; H Machelska; F Pavone
Journal:  Pharmacol Biochem Behav       Date:  1999-03       Impact factor: 3.533

6.  Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is modulated by guanosine 3',5'-cyclic monophosphate.

Authors:  Q Lin; J Wu; Y B Peng; M Cui; W D Willis
Journal:  J Neurophysiol       Date:  1999-03       Impact factor: 2.714

7.  Protein kinase and phosphatase modulation of quail brain GABA(A) and non-NMDA receptors co-expressed in Xenopus oocytes.

Authors:  C Moon; S P Fraser; M B Djamgoz
Journal:  Cell Signal       Date:  2000-02       Impact factor: 4.315

8.  Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura.

Authors:  I Christiansen; L L Thomsen; D Daugaard; V Ulrich; J Olesen
Journal:  Cephalalgia       Date:  1999-09       Impact factor: 6.292

9.  Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery.

Authors:  G R Lauretti; R de Oliveira; M P Reis; A L Mattos; N L Pereira
Journal:  Anesthesiology       Date:  1999-03       Impact factor: 7.892

10.  Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue.

Authors:  Y Choi; S N Raja; L C Moore; J R Tobin
Journal:  J Neurol Sci       Date:  1996-06       Impact factor: 3.181

View more
  35 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  The interdependence of the reactive species of oxygen, nitrogen, and carbon.

Authors:  Walther Bild; Alin Ciobica; Manuela Padurariu; Veronica Bild
Journal:  J Physiol Biochem       Date:  2012-03-29       Impact factor: 4.158

3.  Nitrergic ventro-medial medullary neurons activated during cholinergically induced active (rapid eye movement) sleep in the cat.

Authors:  I Pose; S Sampogna; M H Chase; F R Morales
Journal:  Neuroscience       Date:  2010-10-31       Impact factor: 3.590

4.  Anti-inflammatory and Anti-nociceptive Actions of Systemically or Locally Treated Adipose-Derived Mesenchymal Stem Cells in Experimental Inflammatory Model.

Authors:  Tufan Mert; Akif H Kurt; Mahmut Arslan; Ahmet Çelik; Berin Tugtag; Aysenur Akkurt
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 5.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

Review 7.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

Review 8.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

9.  Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.

Authors:  Yong Chen; Michael K Boettger; Andreas Reif; Angelika Schmitt; Nurcan Uçeyler; Claudia Sommer
Journal:  Mol Pain       Date:  2010-03-02       Impact factor: 3.395

Review 10.  Recent advances in pharmacological treatment of irritable bowel syndrome.

Authors:  Georgia Lazaraki; Grigoris Chatzimavroudis; Panagiotis Katsinelos
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.